Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands. (Q48265414)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28418626%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

title

Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28418626%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28418626%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

David Remillard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28418626%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Gerard L Brien

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28418626%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Jay Bradner

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28418626%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

author name string

Dennis L Buckley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28418626%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Joshiawa Paulk

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28418626%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Matthew Sonnett

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28418626%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Hyuk-Soo Seo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28418626%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Shiva Dastjerdi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28418626%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Sirano Dhe-Paganon

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28418626%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Scott A Armstrong

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28418626%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

language of work or name

English

0 references

publication date

18 April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28418626%20AND%20SRC:MED&resulttype=core&format=json

Angewandte Chemie International Edition

18 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28418626%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28418626%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

issue

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28418626%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

page(s)

5738-5743

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28418626%20AND%20SRC:MED&resulttype=core&format=json

Bromodomain Inhibitor Review: Bromodomain and Extra-terminal Family Protein Inhibitors as a Potential New Therapy in Central Nervous System Tumors

18 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5967236

Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5967236

LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5967236

Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5967236

The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5967236

Inhibition of bromodomain and extra-terminal proteins (BET) as a potential therapeutic approach in haematological malignancies: emerging preclinical and clinical evidence

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5967236

Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4.

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5967236

Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4.

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5967236

DRUG DEVELOPMENT. Phthalimide conjugation as a strategy for in vivo target protein degradation

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5967236

Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5967236

Inhibition of BET bromodomains as a therapeutic strategy for cancer drug discovery

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5967236

9H-purine scaffold reveals induced-fit pocket plasticity of the BRD9 bromodomain

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5967236

Structure of the DDB1–CRBN E3 ubiquitin ligase in complex with thalidomide

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5967236

MultiNotch MS3 enables accurate, sensitive, and multiplexed detection of differential expression across cancer cell line proteomes.

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5967236

Targeting bromodomains: epigenetic readers of lysine acetylation

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5967236

The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5967236

Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy.

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5967236

A comprehensive mathematical model for three-body binding equilibria

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5967236

Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5967236

Suppression of inflammation by a synthetic histone mimic

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5967236

Selective inhibition of BET bromodomains

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5967236

An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5967236

Structural insights into NEDD8 activation of cullin-RING ligases: conformational control of conjugation

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5967236

Chemical genetic control of protein levels: selective in vivo targeted degradation

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5967236

Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5967236

Clinical progress and pharmacology of small molecule bromodomain inhibitors.

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5967236

PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5967236

LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor

16 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FANIE.201611281

Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FANIE.201611281

Machine-assisted synthesis of modulators of the histone reader BRD9 using flow methods of chemistry and frontal affinity chromatography

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FANIE.201611281

The Bromodomain: A New Target in Emerging Epigenetic Medicine

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28418626

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/ANIE.201611281

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28418626%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28418626%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

PubMed publication ID

28418626

1 reference